Colchicine and SARS-CoV-2: Management of the hyperinflammatory state.

Authors:
Vitiello A; Ferrara F.

Journal:
Respir Med

Publication Year: 2021

DOI:
10.1016/j.rmed.2021.106322

PMCID:
PMC7848559

PMID:
33550151

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Respir Med

Abbreviation: Respir Med

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Pulmonary Medicine

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Analysis of inflammatory protein profiles in the circulation of COVID-19 patients identifies patien…
Keur N; Saridaki M; Ricaño-Ponce I and 3 more (2023) - Transparency Score: 4/6
Lung parenchymal abnormalities and outcomes in hospitalized patients with COVID 19 pneumonia: A pos…
Datta B; Prakash AK; Yaddanapudi K and 7 more (2023) - Transparency Score: 3/6
Lung ultrasound as a tool for monitoring the interstitial changes in recently hospitalised patients…
Loke TK; Earl N; Begbey ACH and 7 more (2023) - Transparency Score: 3/6
Multiple manifestations of uncontrolled asthma increase the risk of severe COVID-19.
Selberg S; Karlsson Sundbaum J; Konradsen JR and 4 more (2023) - Transparency Score: 3/6
Pneumothorax in hospitalized COVID-19 patients with severe respiratory failure: Risk factors and ou…
Ragnoli B; Cena T; Radaeli A and 5 more (2023) - Transparency Score: 1/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declaration of competing interest I, The undersigned, Francesco Ferrara and any other author, declare that:•The manuscript was written entirely by the authors;•All authors made an equal contribution in the development of the paper;•We have no conflict of interest;•We have not received funding/source;•There are no sensitive data and no patients were recruited for this study;•The document does not conflict with ethical legislation.•The authors accept the full TRANSFER OF COPYRIGHT to the journal. "

Evidence found in paper:

"The authors have nothing to say about ethical standards, ethical approval and funding. This manuscript is not a clinical trial and does not violate ethical rules. No funding has been received for its preparation."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025